Skip to main content
. 2022 Sep 2;11(9):e36747. doi: 10.2196/36747

Table 2.

Defined groups of participants for each bar of the cascade of care for T2Da.

Bars of the cascade of care for T2D Definitions Questions extracted for analysis
1. Prevalence of the target population living with T2D
  • Participants having biochemical measurement of FBGb (capillary plasma value) ≥126 mg/dl (7 mmol/L) and HbA1cc level ≥6.5% [24,40,41]

  • Measurement of FBG

  • Measurement of HbA1c

  • Have you ever been told by a doctor or other health worker that you have T2D?

  • or Participants reporting use of drugs for T2D, irrespective of their biomarker values

2. Number of the target population with T2D ever tested for T2D
  • Classified patients with T2D having had FBG tested in the last 3 years

  • Have you ever had your blood glucose tested in the last 3 years?

3. Number of those tested ever diagnosed for T2D
  • Tested patients with T2D reporting ever being told by a doctor or other health worker as having T2D

  • Have you ever been told by a doctor or other health worker that you have T2D?

4. Number of those diagnosed in care
  • Diagnosed patients with T2D reporting getting treatment/care for their conditions at least once in the past 12 months

  • Did you get treatment/care for your T2D condition in the past 12 months?

5. Number of those in care receiving treatment
  • In-care patients with T2D reporting using drugs for T2D or insulin in the past 2 weeks or in-care patients with T2D reporting following advice to lose weight, stop smoking, do physical exercise, and be on special prescribed diet

  • Are you currently receiving any of the following treatment/advice for your T2D condition prescribed by a doctor or health care worker?

  • Insulin or drugs (medication) that you have taken in the past 2 weeks

  • Are you currently receiving any of the following treatment/advice for your T2D condition prescribed by a doctor or health care worker?

  • Special prescribed diet and

  • advice to lose weight and

  • advice to stop smoking and

  • advice to start or do more physical exercise

6. Number of those receiving treatment being under control
  • In-treatment patients with T2D having HbA1c level <8% [24]

  • Measurement of HbA1c for the known T2D

aT2D: type 2 diabetes.

bFBG: fasting blood glucose.

cHbA1c: glycated hemoglobin A1c.